Overview

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

Status:
NOT_YET_RECRUITING
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
This study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shandong Suncadia Medicine Co., Ltd.